Gratus Capital LLC Abbott Laboratories Transaction History

Gratus Capital LLC

$2.39 Billion
Q2 2024

A detailed history of Gratus Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gratus Capital LLC holds 4,319 shares of ABT stock, worth $509,469. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,319

Previous 3,621 19.28%

Holding current value

$509,469

Previous $411,000 9.0%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $70,309 - $78,483	698 Added 19.28%	4,319 $448,000
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $201,297 - $222,324	-1,838 Reduced 33.67%	3,621 $411,000
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $123,289 - $150,916	-1,367 Reduced 20.03%	5,459 $600,000
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $40,122 - $48,140	420 Added 6.56%	6,826 $661,000
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $63,189 - $70,405	-627 Reduced 8.92%	6,406 $698,000
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $495,632 - $583,389	-5,117 Reduced 42.12%	7,033 $712,000
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $13,973 - $16,393	-147 Reduced 1.2%	12,150 $0
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $660,580 - $764,828	6,827 Added 124.81%	12,297 $1.19 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $16,535 - $19,985	162 Added 3.05%	5,470 $594,000
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $30,671 - $37,401	-269 Reduced 4.82%	5,308 $628,000
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $241,342 - $295,509	-2,089 Reduced 27.25%	5,577 $785,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $6.28 Million - $6.94 Million	-53,792 Reduced 87.53%	7,666 $906,000
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $798,820 - $940,326	-7,551 Reduced 10.94%	61,458 $7.13 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $1.03 Million - $1.21 Million	-9,445 Reduced 12.04%	69,009 $8.27 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $165,690 - $180,554	1,578 Added 2.05%	78,454 $8.59 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $1.3 Million - $1.58 Million	-14,189 Reduced 15.58%	76,876 $8.37 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $1.19 Million - $1.53 Million	-15,584 Reduced 14.61%	91,065 $8.33 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $866,099 - $1.27 Million	-13,787 Reduced 11.45%	106,649 $8.42 Million
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $30,461 - $33,911	388 Added 0.32%	120,436 $10.5 Million
Q3 2019 Oct 30, 2019	BUY	$81.84 - $88.74 $107,537 - $116,604	1,314 Added 1.11%	120,048 $10 Million
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $141,168 - $164,645	1,937 Added 1.66%	118,734 $9.99 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $880,063 - $1.06 Million	-13,290 Reduced 10.22%	116,797 $9.34 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $69,821 - $79,097	-1,065 Reduced 0.81%	130,087 $9.41 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $261,781 - $296,560	3,993 Added 3.14%	131,152 $9.49 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $186,443 - $224,921	3,066 Added 2.47%	127,159 $9.33 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $131,202 - $144,807	2,279 Added 1.87%	124,093 $7.57 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $1.16 Million - $1.32 Million	-20,674 Reduced 14.51%	121,814 $7.3 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $3.69 Million - $3.95 Million	-68,749 Reduced 32.55%	142,488 $8.13 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $296,530 - $330,958	6,170 Added 3.01%	211,237 $11.3 Million
Q2 2017 Aug 08, 2017	BUY	N/A	205,067	205,067 $9.97 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Abbott Laboratories Transaction History